Early use of biologics recommended in patients with moderate-to-severe Crohn’s disease

FDA approves third COVID-19 antibody treatment for emergency use
27 May 2021
Mass gatherings during Malaysian election directly and indirectly boosted COVID-19 spread
27 May 2021

Early use of biologics recommended in patients with moderate-to-severe Crohn’s disease

Crohn’s disease, a type of inflammatory bowel disease (IBD) that causes inflammation (pain and swelling) in the gastrointestinal tract, can cause daily health problems, frequent hospitalizations and surgery when not adequately controlled. While there is no cure for Crohn’s disease, there are treatments that can help patients live a symptom-free life.

Comments are closed.